Structure-based design of cyclin-dependent kinase inhibitors
- 1 February 2002
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 93 (2-3), 125-133
- https://doi.org/10.1016/s0163-7258(02)00182-1
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- The Sequence of the Human GenomeScience, 2001
- Initial sequencing and analysis of the human genomeNature, 2001
- Mechanisms of cyclin-dependent kinase regulation: structures of cdks, their cyclin activators, and cip and INK4 inhibitors1,2Journal of Molecular Biology, 1999
- Active Transcriptional Repression by the Rb–E2F Complex Mediates G1 Arrest Triggered by p16INK4a, TGFβ, and Contact InhibitionCell, 1999
- Chemical inhibitors of cyclin-dependent kinasesTrends in Cell Biology, 1996
- Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpointCell, 1995
- Win some, lose some: enthalpy-entropy compensation in weak intermolecular interactionsCell Chemical Biology, 1995
- Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complexNature, 1995
- Inhibition of Cyclin‐Dependent Kinases by Purine AnaloguesJBIC Journal of Biological Inorganic Chemistry, 1994
- A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine KinaseScience, 1994